Dr Kaitin writes and speaks frequently on factors that contribute to the slow pace and high cost of pharmaceutical R&amp,D and the impact of efforts to speed the drug development process.

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could revolutionize the drug industry. The safer, cheaper, more environmentally friendly ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

We have been following the use of AI in drug development in our work as a pharmaceutical scientist in both academia ... could help address the root causes of drug failure and streamline the process.

Nitrogen atoms and nitrogen-containing chemical structures, known as heterocycles, play a crucial role in medicinal chemistry ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

Did you know that back in the 1980s and '90s, when South Korea was on the road toward becoming—but had yet to become—the ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

ASTX-295 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 37% phase transition success ...

TAS-1440 is under clinical development by Taiho Pharmaceutical and currently in Phase I for Refractory Acute Myeloid Leukemia.

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug ...